News

Hypertension is one of the major conditions associated with the development of cardiovascular disease, stroke, and kidney disease. Although pharmacological treatment is essential when indicated, lifestyle changes—particularly dietary changes—are also an important part of treatment. When discussing hypertension and nutrition, however, recommendations are often reduced to a single phrase: “eat less salt.” Reducing excessive sodium intake is indeed important. However, the relati

When we talk about breast cancer, questions often arise, such as: Are there foods that increase the risk? Is there a diet that can prevent the disease? And after a breast cancer diagnosis, can changing your diet make a difference? The answer requires some caution. Breast cancer is a complex, multifactorial disease. Age, genetics, reproductive history, hormonal exposure, body weight, physical activity, alcohol consumption, and other factors all play a role in determining risk.

Have you ever heard that cooking rice, refrigerating it, and reheating it the next day may cause a smaller rise in blood glucose? Although this may sound like just another tip circulating on social media, there is a biochemical explanation for this phenomenon—and human studies have already investigated how blood glucose responds when we change how rice is prepared and stored. At the center of this story is resistant starch. The main carbohydrate in rice is starch, which is co

Retatrutide has become one of the most widely discussed investigational drugs for obesity treatment. And there is a reason for that: the results of clinical trials have been remarkable. In Phase 3 trials, participants receiving the highest doses experienced average weight reductions approaching 30% of their initial body weight—a magnitude that, until recently, was difficult to imagine with pharmacological treatment. But an increasingly common question is emerging in medical c

Do semaglutide and tirzepatide increase the risk of depression, anxiety, or suicidal thoughts? Medications popularly known as “weight-loss injections” have transformed the treatment of obesity. Semaglutide, liraglutide, and, more recently, tirzepatide have made it possible to achieve levels of weight loss that were previously difficult to attain through lifestyle changes alone. At the same time, as millions of people began using these medications, an important concern emerged

GLP-1 receptor agonists, medications that have gained enormous prominence in the treatment of type 2 diabetes and, particularly, obesity, are now becoming part of a discussion that goes far beyond weight loss: what role might these medications play in people with cancer? At ASCO 2026, the world’s leading oncology meeting, new studies reported highly interesting findings. In some analyses, patients with cancer who were taking GLP-1 receptor agonists had lower rates of progress

Medications popularly known as “weight-loss injections,” particularly GLP-1 receptor agonists, have transformed the treatment of obesity and type 2 diabetes. In recent years, however, scientists have begun investigating a much broader question: could these medications also help protect the brain and contribute to healthier aging? Recent studies have raised intriguing hypotheses about a possible association between GLP-1 receptor agonists, a lower risk of dementia, and benefit

GLP-1–based medications have transformed the treatment of obesity. Semaglutide, tirzepatide, and other drugs in this therapeutic class can lead to substantial weight loss and important metabolic benefits. However, as their use has increased, questions have also emerged regarding possible changes in the skin, face, and hair. Skin laxity, loss of facial volume, a more aged appearance, and hair loss are among the concerns reported during treatments that result in significant wei

GLP-1 receptor agonists, such as semaglutide, and medications that act on both GIP and GLP-1 receptors, such as tirzepatide, have transformed the treatment of obesity. In addition to producing substantial weight loss, these medications can improve several metabolic outcomes. However, as increasingly significant weight loss has become achievable with pharmacological treatment, an important question has emerged: How much of the weight lost is fat, and how much is lean or muscle

Hair loss has been increasingly reported by people using medications for obesity treatment, particularly GLP-1 receptor agonists and related therapies, such as semaglutide and tirzepatide. But do these medications actually cause hair loss? Recent studies suggest an association between these treatments and certain types of alopecia, but the available evidence does not yet establish that GLP-1–based medications directly cause hair loss. The explanation is likely more complex an

Armed thugs have ramped up pharmacy raids to meet the ballooning demand for fat jabs, a local doctor told The Sun Harvey Geh Published: 16:46, 29 Dec 2025 At the end of 2025, I had the honor of being interviewed by Harvey Geh, who was interested in a story for The Sun about obesity in Brazil. I am very honored to have been chosen to represent Brazilian doctors who work with this very challenging disease. INSIDE the world’s obesity capital, it’s not just the locals who are la

A healthy, balanced diet improves the uncomfortable symptoms some women experience during their menstrual cycle. The different phases of...

Does this medicinal plant help to improve diabetes? Bardana or burdock, the species Arctium Lappa and the Asteraceae family, is a...

A chia é um alimento saudável que pode ajudar na perda de peso.

Apple cider vinegar is a type of vinegar made by fermenting apples, although many news stories on the internet have talked about its...